|
Dr. Shah is a Partner at Thomas, McNerney & Partners. He was previously the Chief Business Officer and co-founder of Kalypsys, Inc., a biopharmaceutical company focused on the discovery and clinical development of new medicines for cancer, inflammation and metabolic disease. While at Kalypsys, Dr. Shah was responsible for the overall strategy, business development and operations of the company and oversaw raising more than $130 million in equity financings and corporate deals. Prior to co-founding Kalypsys, Dr. Shah was at McKinsey & Company in San Francisco, where he focused on biotechnology and venture capital projects. He was formerly co-founder and VP of Operations at NephRx Corporation, a start-up company focused on the discovery of therapeutic proteins for renal disease. Dr. Shah holds a Ph.D. in Biochemistry & Molecular Biology and an M.B.A. in Finance from the University of Chicago. | 